A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Persistence of Rubella Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine
2009
Journal of Infectious Diseases
Background. Since 1990, most schoolchildren in the United States have received a second dose of measlesmumps-rubella vaccine (MMR2) at kindergarten entry. Elimination of endemic rubella virus circulation in the United States was declared in 2004. The objective of the current study was to evaluate the short-and long-term rubella immunogenicity of MMR2. Methods. At enrollment in 1994-1995, children ( ) in a rural Wisconsin health maintenance organi-n p 307 zation received MMR2 at age 4-6 years. A
doi:10.1086/605410
pmid:19659440
fatcat:cbl3rd3svjdidfvrecd5a3pv3i